Bereich
Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen
ENDO · Dept. I
A patient with a "good nose"
Sze L, Fretz C, Hildebrandt G, Westphal K, Brändle M. A patient with a "good nose". Exp Clin Endocrinol Diabetes 2007; 116:129-31.
20.12.2007A patient with a "good nose"
20.12.2007Exp Clin Endocrinol Diabetes 2007; 116:129-31
Sze Lisa, Fretz C, Hildebrandt G, Westphal K, Brändle M
Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%)
Preusser S, Diener P, l'Allemand-Jander D, Schmid S, Leippold T, Brändle M, Schmid H. Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%). Urology 2007; 70:1223.e7-9.
01.12.2007Scrotal hysterectomy in a male patient with mixed gonadal dysgenesis 46,XY(75%)/45,X(25%)
01.12.2007Urology 2007; 70:1223.e7-9
Preusser Stefan, Diener Pierre-André, l'Allemand-Jander Dagmar, Schmid Sacha, Leippold Thomas, Brändle Michael, Schmid Hans-Peter
National survey on the management of primary hyperparathyroidism by Swiss endocrinologists
Clerici T, Warschkow R, Triponez F, Brändle M. National survey on the management of primary hyperparathyroidism by Swiss endocrinologists. Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007; 392:611-5.
01.09.2007National survey on the management of primary hyperparathyroidism by Swiss endocrinologists
01.09.2007Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007; 392:611-5
Clerici Thomas, Warschkow Rene, Triponez F, Brändle Michael
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
Valentine W, Massi-Benedetti M, Tan M, Yates J, Dormandy J, Williams R, Foos V, Brändle M, Palmer A, Bottomley J, PROactive Study Group. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002.
01.09.2007PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
01.09.2007Diabetic medicine : a journal of the British Diabetic Association 2007; 24:982-1002
Valentine W J, Massi-Benedetti M, Tan M H, Yates J, Dormandy J A, Williams R, Foos V, Brändle Michael, Palmer A J, Bottomley J M, PROactive Study Group
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen K, Rothman D, Papademetris X, Kahn B, Zemany L, Befroy D, Cline G, Yonemitsu S, Solomon G, Bilz S, Savage D, Dufour S, Shulman G. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2007; 104:12587-94.
31.07.2007The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
31.07.2007Proceedings of the National Academy of Sciences of the United States of America 2007; 104:12587-94
Petersen Kitt Falk, Rothman Douglas L, Papademetris Xenophon, Kahn Barbara B, Zemany Laura, Befroy Douglas, Cline Gary W, Yonemitsu Shin, Solomon Gina, Bilz Stefan, Savage David B, Dufour Sylvie, Shulman Gerald I
To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?
Müller-Stich B, Brändle M, Binet F, Warschkow R, Lange J, Clerici T. To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?. Surgery 2007; 142:47-56.
01.07.2007To autotransplant simultaneously or not -- can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia?
01.07.2007Surgery 2007; 142:47-56
Müller-Stich Beat P, Brändle Michael, Binet Françoise-Isabelle, Warschkow Rene, Lange Jochen, Clerici Thomas
Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome
Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B, Sticherling C, Müller B, Osswald S. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. Journal of the American College of Cardiology 2007; 49:2350-5.
19.06.2007Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome
19.06.2007Journal of the American College of Cardiology 2007; 49:2350-5
Conen David, Melly Ludovic, Kaufmann Christoph, Bilz Stefan, Ammann Peter, Schaer Beat, Sticherling Christian, Müller Beat, Osswald Stefan
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
Schimke K, Davis T. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes. Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44.
01.04.2007Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
01.04.2007Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44
Schimke Katrin-Elisabeth, Davis Timothy M E
Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
Brändle M, Azoulay M, Greiner R. Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland. International journal of clinical pharmacology and therapeutics 2007; 45:203-20.
01.04.2007Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland
01.04.2007International journal of clinical pharmacology and therapeutics 2007; 45:203-20
Brändle Michael, Azoulay M, Greiner R A
Current perspectives on coronary revascularization in the diabetic patient
Roffi M, Brändle M, Robbins M, Mukherjee D. Current perspectives on coronary revascularization in the diabetic patient. Indian heart journal 2007; 59:124-36.
07.03.2007Current perspectives on coronary revascularization in the diabetic patient
07.03.2007Indian heart journal 2007; 59:124-36
Roffi Marco, Brändle Michael, Robbins Mark A, Mukherjee Debabrata
Effect of transsphenoidal surgery on sleep apnoea in acromegaly
Sze L, Schmid C, Bloch K, Bernays R, Brändle M. Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol 2007; 156:321-9.
01.03.2007Effect of transsphenoidal surgery on sleep apnoea in acromegaly
01.03.2007Eur J Endocrinol 2007; 156:321-9
Sze Lisa, Schmid Christoph, Bloch Konrad E, Bernays René, Brändle Michael
Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes
Renström F, Burén J, Svensson M, Eriksson J. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Metab Clin Exp 2007; 56:190-8.
01.02.2007Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes
01.02.2007Metab Clin Exp 2007; 56:190-8
Renström Frida, Burén Jonas, Svensson Maria, Eriksson Jan W
Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'
Lundgren M, Svensson M, Lindmark S, Renström F, Ruge T, Eriksson J. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007; 50:625-33.
10.01.2007Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'
10.01.2007Diabetologia 2007; 50:625-33
Lundgren M, Svensson M, Lindmark S, Renström Frida, Ruge T, Eriksson J W
Diabetes
Brändle M. Diabetes - Patient Selection. In: Textbook of Interventional Cardiology. 5th EditionPhiladelphia, PA: Saunders Elsevier, 2007. ISBN 978-1-4160-4835-0. S. 23-50.
01.01.2007Diabetes
01.01.2007Saunders Elsevier, ISBN 978-1-4160-4835-0
Brändle Michael
The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
Schmid C, Brändle M. The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical endocrinology 2006; 65:827-8.
01.12.2006The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
01.12.2006Clinical endocrinology 2006; 65:827-8
Schmid Christoph, Brändle Michael
Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism
Schmid C, Zwimpfer C, Brändle M, Krayenbühl P, Zapf J, Wiesli P. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism. Clinical endocrinology 2006; 65:706-11.
01.12.2006Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism
01.12.2006Clinical endocrinology 2006; 65:706-11
Schmid Christoph, Zwimpfer Cornelia, Brändle Michael, Krayenbühl Pierre-Alexandre, Zapf Jürgen, Wiesli Peter
Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia
Puder J, Varga S, Nusbaumer C, Zulewski H, Bilz S, Müller B, Keller U. Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia. European journal of clinical investigation 2006; 36:883-9.
01.12.2006Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia
01.12.2006European journal of clinical investigation 2006; 36:883-9
Puder J J, Varga S, Nusbaumer C P G, Zulewski H, Bilz Stefan, Müller B, Keller U
Severe hypernatraemia due to nephrogenic diabetes insipidus - a life-threatening side effect of chronic lithium therapy
Sze L, Ulrich B, Brändle M. Severe hypernatraemia due to nephrogenic diabetes insipidus - a life-threatening side effect of chronic lithium therapy. Exp Clin Endocrinol Diabetes 2006; 114:596-8.
01.11.2006Severe hypernatraemia due to nephrogenic diabetes insipidus - a life-threatening side effect of chronic lithium therapy
01.11.2006Exp Clin Endocrinol Diabetes 2006; 114:596-8
Sze Lisa, Ulrich B, Brändle M
Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma
Walter M, Wild D, Rasch H, Müller-Brand J, Müller B, Bilz S. Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma. Thyroid : official journal of the American Thyroid Association 2006; 16:1063-4.
01.10.2006Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma
01.10.2006Thyroid : official journal of the American Thyroid Association 2006; 16:1063-4
Walter Martin A, Wild Damian, Rasch Helmut, Müller-Brand Jan, Müller Beat, Bilz Stefan
Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients
Christ-Crain M, Müller B, Bergmann A, Struck J, Korbonits M, Bilz S, Morgenthaler N, Ernst A, Stoeckli R, Keller U. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients. The Journal of clinical endocrinology and metabolism 2006; 91:3544-7.
01.09.2006Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients
01.09.2006The Journal of clinical endocrinology and metabolism 2006; 91:3544-7
Christ-Crain Mirjam, Müller Beat, Bergmann Andreas, Struck Joachim, Korbonits Márta, Bilz Stefan, Morgenthaler Nils G, Ernst Andrea, Stoeckli Rolf, Keller Ulrich